Medical Aesthetics’ record-breaking trajectory restarts post-covid.
Telemedicine and telediagnostic have more than tripled from 11% in 2019 to 46% in 2020 and a study by Frost and Sullivan predicts that telemedicine market in the US will see a seven-fold growth in market share by 2025 AESTHETICS which ARE RECOGNIZED AS ESSENTIAL TREATMENTS . The Zoom-Boom liberated the pent-up demand and paved the way for telemedicine, fostered by the emergence of a tech-empowered, sophisticated and demanding client-base, personalization, machine and deep learning, quantitative analytics 2021 aesthetics were propelled by a skyrocketing economic rebound, booming M&A catalyzed by unprecedented fiscal stimulus and a recovery of the Aesthetics Sectors following the reopening euphoria and explosion of pent-up demand Massive liquidity injections into the financial systems by all major Central Banks fueled the M&A surge.
This ramp-up started perceptibly in Q4 2020 when the first major economies emerged from the pandemic and then gained traction, powered by shift of gravity of strategic Buyers from the US to China while the PEs keep the upper hand in the US Phenomenal traction accelerating in Q1 2022 with lots of transactions with record-breaking multiples.
Nevertheless, mounting geopolitical uncertainties in Q2 2022, rise in interest rates, and end of monetary expansion, and increasing inflation pose a major threat to the sustainability of these trends.
